首页
400-620-6333
应用
选项
-
Recombinant Human HVEM/TNFRSF14 Protein种属: 人(Human) Accession #: Q92956-1表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to inhibit TNF-beta -mediated cytotoxicity using L‑929 mouse fibroblast cells. The ED50 for this effect is 2.5-10 µg/mL in the presence of 50 pg/mL of Recombinant Human TNF‑ beta /TNFSF1.
-
Recombinant Human TGF-beta 1 Protein种属: 人(Human) Accession #: P01137表达系统: HEK293 蛋白标签: N-8His 内毒素水平: <0.1 EU/μg生物活性: 1、Measured by its ability to inhibit the IL-4-dependent proliferation of TF‑1 human erythroleukemic cells. The ED50 for this effect is 0.34 ng/mL in the presence of the 2.0 ng/mL Recombinant Mouse IL-4 Protein (rp154228). 2、Measured by its ability to inhibit the IL-4-dependent proliferation of HT‑2 mouse T cells. The ED50 for this effect is 35.9 ng/mL.
-
Recombinant Mouse IL-6 Protein种属: 小鼠(Mouse) Accession #: P08505表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured in a cell proliferation assay using NFS-60 mouse myelogenous leukemia lymphoblast cells. The ED50 for this effect is 0.07-0.28 ng/mL, corresponding to a specific activity of 3.57×10^6 ~ 1.43×10^7 units/mg.
-
Recombinant Feline CD56 Protein种属: 猫(Feline) Accession #: Q5G7G8表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg
-
Recombinant Human HGFR/c-MET Protein种属: 人(Human) Accession #: P08581表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human HGFR/c-MET Protein (rp169642) at 1.0 μg/mL can bind Recombinant human HGF protein (rp175908) with the ED50 is 97.73 ng/mL.
-
Recombinant Human CD90/Thy1 Protein种属: 人(Human) Accession #: P04216表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human CD90/Thy1 Protein (rp183754) at 2.0 μg/mL can bind CD90/Thy1 Mouse mAb (Ab095497) with the EC50 of 287.4 ng/mL.
-
Recombinant Mouse MAdCAM-1 Protein种属: 小鼠(Mouse) Accession #: G5E838表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by the ability of the immobilized protein to support the adhesion of HuT 78 human cutaneous T cell lymphoma cells. When 5 x 104 cells/well are added to mouse MAdCAM-1/Fc Chimera coated plates (10 µg/mL with 100 µL/well), approximately 80-90% will adhere after MnCl2 stimulation for 1 hour incubation at room temperature.
-
Recombinant Human NCAM-1/CD56 Protein种属: 人(Human) Accession #: P13591-3表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Measured by the ability of the immobilized protein to support the adhesion of SK-N-SH human neuroblastoma cells. The ED50 for this effect is 1.0 - 10.0 μg/mL. Measured by its binding ability in a functional ELISA. Immobilized Human NCAM-1/CD56 Protein (rp175917) at 1.0 μg/mL can bind Lorvotuzumab (anti-CD56) with the EC50 of 28.65 ng/mL.
-
Recombinant Human TROP-2 Protein种属: 人(Human) Accession #: P09758表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Measured by the ability of the immobilized protein to support the adhesion of U937 human histiocytic lymphoma cells. The ED50 for this effect is 0.72 μg/mL.
-
Recombinant Human DDR1 Protein种属: 人(Human) Accession #: Q08345表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Testing in progress
-
Recombinant Human MMP-9 Protein种属: 人(Human) Accession #: P14780表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: 1. Measured in a cell migration assay using A549 cells. 5.0 ng/mL of Recombinant Human MMP-9 can effectively induce A549 cells migration. 2. Immobilized Recombinant Human MMP-9 Protein (rp181214) at 1.0 μg/mL can bind Andecaliximab (anti-MMP9), the EC50 for this effect is 12.14 ng/mL.
-
Recombinant Human PD-L1 Protein种属: 人(Human) Accession #: Q9NZQ7表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human PD-L1 Protein (rp169666) at 2.0 μg/mL can bind Sugemalimab (anti-PD-L1) (Ab175662) with the EC50 of 169.70 ng/mL. Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Avelumab (anti-PD-L1) (A412006) with the EC50 of 77.96 ng/mL. Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Envafolimab (anti-PD-L1) (Ab170617) with the EC50 of 339.40 ng/mL. Immobilized Recombinant Human PD-L1 Protein (rp169666) at 1.0 μg/mL can bind Durvalumab (anti-PD-L1) (D412005) with the EC50 of 35.40 ng/mL.
